Dr. Jay Lombard, a neurologist, is the co-founder and chief scientific officer of Genomind (Chalfont, Pennsylvania), a company focused on improving the lives of patients with psychiatric and neurological conditions through biomarker discovery. Lombard has researched and developed several novel therapeutic interventions to treat depression, dementia, and autism.

For years, numerous companies have been developing implantable devices to stimulate the vagal nerve for treatment of such diverse conditions as epilepsy, depression, asthma, chronic obstructive pulmonary disease (COPD), cluster headaches and for weight loss. Now, a company has come along with a potentially game changing technology that can non-invasively stimulate the vagal nerve.